Breaking News, Promotions & Moves

Probiodrug Appoints Business & Strategy EVP

Dr. Michael Schaeffer brings more than 15 years of experience across pharma and biotech in strategic business development

Probiodrug AG announced that Dr. Michael Schaeffer has been appointed to the position of executive vice president of Business and Strategy, effective August 2018.    Dr. Schaeffer brings more than 15 years of experience across pharma and biotech in strategic business development, scientific project and alliance management to Probiodrug. Chief executive officer of Probiodrug, Dr. Ulrich Dauer, said, “We are very pleased Michael has joined our team. His entrepreneurial skill sets and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters